Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst TOIIW 深 滬
已收盤 08-05 16:00:00 美东时间
0.049
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.049
- 總市值 0
- 52周最高 0.2725
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.025
- 委 比 0.00%
- 總股本 --
- 歷史最高 3.86
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多The Oncology Institute Q2 EPS $(0.08) Misses $(0.06) Estimate, Sales $161.282M Beat $155.193M Estimate
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $161.2...
08-07 05:28
Starling Oncology Unveils New Nasdaq Ticker Symbol
Oncology Institute ( ($TOI) ) has shared an announcement. In late July 2026, Th...
08-03 21:54
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
The Oncology Institute, Inc. (TOI) announced it will release its second quarter 2026 financial results on August 6, 2026, followed by a conference call at 5:00 p.m. Eastern Time. The call can be accessed via phone using the provided numbers and Conference ID: TOI, or through a webcast on the company’s Investor Relations website. A replay will be available three hours after the call until August 20, 2026. TOI, a leader in value-based oncology care...
07-27 13:00
BTIG’s top small and mid-cap stocks for H2, ranked by SA Quant
BTIG analysts selected their favorite stock picks over a 12-month investment period within the small- and mid-cap space for the second half of the year. These are BTIG’s highest conviction investment ...
07-02 00:32
These low-priced stocks are flashing overbought signals
Stocks trading below $10 often attract retail investors looking for high-growth opportunities at relatively low entry prices. However, many of these low-priced equities can become overheated during st...
06-02 18:23
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
The Oncology Institute, Inc. (NASDAQ: TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the B. Riley Securities Institutional Investor Conference on May 21, 2026, in Marina Del Rey, CA. They will engage in a fireside chat from 9:00–9:40 a.m. PT. A webcast of the presentation will be available via the Company’s Investor Relations website. Founded in 2007, TOI provides specialized, value-based cancer care to approxim...
05-13 13:00
